125 related articles for article (PubMed ID: 38940430)
1. NUP98-BPTF promotes oncogenic transformation through PIM1 upregulation.
Noura M; Tomita S; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Cancer Med; 2024 Jul; 13(13):e7445. PubMed ID: 38940430
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic insights into chromatin targeting by leukemic NUP98-PHF23 fusion.
Zhang Y; Guo Y; Gough SM; Zhang J; Vann KR; Li K; Cai L; Shi X; Aplan PD; Wang GG; Kutateladze TG
Nat Commun; 2020 Jul; 11(1):3339. PubMed ID: 32620764
[TBL] [Abstract][Full Text] [Related]
3. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
Kim J; Roh M; Abdulkadir SA
BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
Sarma NJ; Yaseen NR
J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the NUP98-CCDC28A fusion protein.
Petit A; Ragu C; Soler G; Ottolenghi C; Schluth C; Radford-Weiss I; Schneider-Maunoury S; Callebaut I; Dastugue N; Drabkin HA; Bernard OA; Romana S; Penard-Lacronique V
Haematologica; 2012 Mar; 97(3):379-87. PubMed ID: 22058212
[TBL] [Abstract][Full Text] [Related]
6. CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.
Schmoellerl J; Barbosa IAM; Eder T; Brandstoetter T; Schmidt L; Maurer B; Troester S; Pham HTT; Sagarajit M; Ebner J; Manhart G; Aslan E; Terlecki-Zaniewicz S; Van der Veen C; Hoermann G; Duployez N; Petit A; Lapillonne H; Puissant A; Itzykson R; Moriggl R; Heuser M; Meisel R; Valent P; Sexl V; Zuber J; Grebien F
Blood; 2020 Jul; 136(4):387-400. PubMed ID: 32344427
[TBL] [Abstract][Full Text] [Related]
7. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
8. Retroviral insertional mutagenesis identifies genes that collaborate with NUP98-HOXD13 during leukemic transformation.
Slape C; Hartung H; Lin YW; Bies J; Wolff L; Aplan PD
Cancer Res; 2007 Jun; 67(11):5148-55. PubMed ID: 17545593
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract][Full Text] [Related]
10. Dissection of PIM serine/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration.
Grundler R; Brault L; Gasser C; Bullock AN; Dechow T; Woetzel S; Pogacic V; Villa A; Ehret S; Berridge G; Spoo A; Dierks C; Biondi A; Knapp S; Duyster J; Schwaller J
J Exp Med; 2009 Aug; 206(9):1957-70. PubMed ID: 19687226
[TBL] [Abstract][Full Text] [Related]
11. NUP98-BPTF gene fusion identified in primary refractory acute megakaryoblastic leukemia of infancy.
Roussy M; Bilodeau M; Jouan L; Tibout P; Laramée L; Lemyre E; Léveillé F; Tihy F; Cardin S; Sauvageau C; Couture F; Louis I; Choblet A; Patey N; Gendron P; Duval M; Teira P; Hébert J; Wilhelm BT; Choi JK; Gruber TA; Bittencourt H; Cellot S
Genes Chromosomes Cancer; 2018 Jun; 57(6):311-319. PubMed ID: 29427526
[TBL] [Abstract][Full Text] [Related]
12. PIM1 overexpression in T-cell lymphomas protects tumor cells from apoptosis and confers doxorubicin resistance by upregulating c-myc expression.
Xiang X; Yuan D; Liu Y; Li J; Wen Q; Kong P; Gao L; Zhang C; Gao L; Peng X; Zhang X
Acta Biochim Biophys Sin (Shanghai); 2018 Aug; 50(8):800-806. PubMed ID: 30020405
[TBL] [Abstract][Full Text] [Related]
13. The role of Nup98 in transcription regulation in healthy and diseased cells.
Franks TM; Hetzer MW
Trends Cell Biol; 2013 Mar; 23(3):112-7. PubMed ID: 23246429
[TBL] [Abstract][Full Text] [Related]
14. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
Nakamura T
Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
[TBL] [Abstract][Full Text] [Related]
15. [Development of human myeloid leukemia-like phenotype in NUP98-PMX1 transgenic mice].
Wang Y; Gu MM; Tan Y; Lu SY; Wang L; Kong H; Sun YP; Lu ZY; Chen SJ; Wang ZY; Wang ZG
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):262-5. PubMed ID: 15182531
[TBL] [Abstract][Full Text] [Related]
16. Loss of Toll-like receptor 2 results in accelerated leukemogenesis in the
Monlish DA; Bhatt ST; Duncavage EJ; Greenberg ZJ; Keller JL; Romine MP; Yang W; Aplan PD; Walter MJ; Schuettpelz LG
Blood; 2018 Mar; 131(9):1032-1035. PubMed ID: 29358180
[No Abstract] [Full Text] [Related]
17. NUP98-HOXA9-transgenic zebrafish develop a myeloproliferative neoplasm and provide new insight into mechanisms of myeloid leukaemogenesis.
Forrester AM; Grabher C; McBride ER; Boyd ER; Vigerstad MH; Edgar A; Kai FB; Da'as SI; Payne E; Look AT; Berman JN
Br J Haematol; 2011 Oct; 155(2):167-81. PubMed ID: 21810091
[TBL] [Abstract][Full Text] [Related]
18. Regulation of differentiation by a PHD domain in the NUP98-PHF23 fusion protein.
Reader JC; Leng Q; Rassool FV; Ning Y
Leuk Res; 2010 Aug; 34(8):1094-7. PubMed ID: 20219246
[TBL] [Abstract][Full Text] [Related]
19. SMARCA5 interacts with NUP98-NSD1 oncofusion protein and sustains hematopoietic cells transformation.
Jevtic Z; Matafora V; Casagrande F; Santoro F; Minucci S; Garre' M; Rasouli M; Heidenreich O; Musco G; Schwaller J; Bachi A
J Exp Clin Cancer Res; 2022 Jan; 41(1):34. PubMed ID: 35073946
[TBL] [Abstract][Full Text] [Related]
20. Trans-repressive effect of NUP98-PMX1 on PMX1-regulated c-FOS gene through recruitment of histone deacetylase 1 by FG repeats.
Bai XT; Gu BW; Yin T; Niu C; Xi XD; Zhang J; Chen Z; Chen SJ
Cancer Res; 2006 May; 66(9):4584-90. PubMed ID: 16651408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
